169872-81-5

Upstream product

• 108-95-2 phenol 
• 128741-00-4 (1S,4R)-cis-1-ethoxycarbonyloxy-4-acetoxy-2-cyclopentene 
• 60410-16-4 (1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate 
• 54664-61-8 cis-1,4-diacetoxy-2-cyclopentene 
• 210701-09-0 1-acetoxy-4-phenoxy-2-cyclopentene 
• 7129-41-1 6-oxabicyclo[3.1.0]hex-2-ene 
• 108-22-5 Isopropenyl acetate 
• 103056-56-0 (+/-)-cis-4-phenyloxy-2-cyclopenten-1-ol 

Downstream Products

• 210701-06-7 1-Bromo-2-((1S,4S)-4-phenoxy-cyclopent-2-enyloxy)-benzene 
• 210701-08-9 (1S,4S)-trans-1-phenoxy-4-(2,4,6-tribromophenoxy)-2-cyclopentene 

Relevant academic research and scientific papers

Process for producing cycloalkyl [b]benzofurans

The present invention provides a process for producing an optically active compound of cycloalkyl[b]benzofuran using a readily available optically active compound as a starting material by a reaction using a transition metal or the Mitsunobu reaction, or

Synthesis of optically active cyclopenta[b]benzofuran as a precursor of m-phenyleneprostacyclin

The optically pure cyclopenta[b]benzofuran derivatives (-)-1 and (-)-2 were synthesized from (+)-(1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol [(+)-3] via sequential Mitsunobu reaction and palladium-catalyzed allylic substitution with phenol derivatives followed by SN2′ intramolecular cyclization.

Chemoenzymatic synthesis of trans-4,5-dihydroxycyclopent-2-enones: Conversion to D-1-deoxynojirimycin

(4R,5S)-trans-4,5-Bis(tert-butyldimethylsilyloxy)cyclopent-2-enone 8 and (4R,5S)-trans-4,5-di(benzyloxy)cyclopent-2-enone 20 are prepared by equilibration of the corresponding cis derivatives; enone 8 is transformed into the glucosidase inhibitor, D-1-deoxynojirimycin 14.